Achieve Life Sciences, Inc.
Achieve Life Sciences, Inc. scores highest on Nitro (78) and lowest on Price (0). Its PosiPenta is 34.91 out of 100, weaker than most similar companies.
On the Penta Grid this week, Achieve Life Sciences, Inc. is Grid #675 of 837 in the Healthcare sector in United States, and Grid #3,308 of 4,000 in United States.
Compared with similar companies in the Healthcare sector in United States.
The five pillars
Similar companies
| Company | PosiPenta | P | E | N | T | A |
|---|---|---|---|---|---|---|
| Achieve Life Sciences, Inc. | 34.91 | 0 | 50 | 78 | 14 | 33 |
| Aura Biosciences, Inc. | 45.05 | 29 | 26 | 61 | 52 | 57 |
| Prime Medicine, Inc. | 39.49 | 48 | 41 | 52 | 8 | 49 |
| Solid Biosciences Inc. | 38.31 | 32 | 31 | 48 | 49 | 31 |
| Lexicon Pharmaceuticals, Inc. | 41.25 | 17 | 44 | 56 | 45 | 44 |
| Attovia Therapeutics, Inc. | 36.71 | 0 | 28 | 38 | 62 | 55 |
Similar-sized companies in the same sector, this week. P Price · E Earnings · N Nitro · T Torque · A Anchor.
Details
PPrice
| P/E ratio | -3.78 |
| P/B ratio | -44.82 |
EEarnings
| Trailing EPS | ₹-160.07 |
| Forward EPS | ₹-61.80 |
NNitro
| Price | 604.28 |
| 52-week high | 818.34 |
| 52-week low | 248.15 |
| Fall from 52-week high | 26.2% |
TTorque
| Return on equity (ROE) | -844.99% |
| Debt-to-equity | 0.69 |
AAnchor
| Beta (price swings) | 2.31 |
| Market cap | ₹6,230 Cr |
| Insider holding | 0.91% |
| Dividend yield | 0.00% |
Figures as used for the week of 17 Oct 2026; today's figures on the company page may differ slightly.
Questions
What is Achieve Life Sciences, Inc.'s PosiPenta score?
Achieve Life Sciences, Inc.'s PosiPenta is 34.91 out of 100 for the week of 17 Oct 2026, based on 5 of 5 pillars.
Where does Achieve Life Sciences, Inc. stand on the Penta Grid?
On the Penta Grid this week, Achieve Life Sciences, Inc. is Grid #675 of 837 in the Healthcare sector in United States, and Grid #3,308 of 4,000 in United States.
Which PosiPenta pillar is strongest for Achieve Life Sciences, Inc.?
Nitro (momentum), with a score of 78 out of 100: better than most similar companies.
Which PosiPenta pillar is weakest for Achieve Life Sciences, Inc.?
Price (valuation), with a score of 0 out of 100: much weaker than most similar companies.
Has Achieve Life Sciences, Inc.'s PosiPenta changed since last week?
Yes, it rose 1.01 points, from 33.90 to 34.91.
PositoAI is for research and education only and is not investment advice.